Lexiscan stress agent now available

Article

Radionuclide imaging agent Lexiscan is now commercially available.

Astellas Pharma has announced the availability of regadenoson (Lexiscan injection) for use as a pharmacologic stress agent. Regadenoson was co-developed by CV Therapeutics and, according to the manufacturer, is the first A2A adenosine receptor agonist to be used in myocardial perfusion imaging. The new agent will be used for patients undergoing cardiac stress tests who are unable to exercise for medical reasons.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, click here.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!
Recent Videos
Related Content
Collaborative Care Approaches Can Improve Provider Shortage, Pharmacist-Physician Relationships | ACCP 2024

Collaborative Care Approaches Can Improve Provider Shortage, Pharmacist-Physician Relationships | ACCP 2024

Brian Nowosielski
October 17th 2024
Article

In posters presented at the American College of Clinical Pharmacy 2024 Annual Meeting, researchers explored the implementation of collaborative care programs within various health systems.

FTC Files Lawsuit Against ‘Big 3’ PBMs for Drug Price Inflation

FTC Files Lawsuit Against ‘Big 3’ PBMs for Drug Price Inflation

Brian Nowosielski
September 20th 2024
Article

In its first move since the July interim report detailing pharmacy benefit manager practices, the FTC is now suing CVS Caremark, Express Scripts, and Optum Rx.

Pharmacists’ Ability to Close Gap in Delivery of Oral Anticoagulation Therapy

Pharmacists’ Ability to Close Gap in Delivery of Oral Anticoagulation Therapy

Brian Nowosielski
August 2nd 2024
Article

Researchers aimed to discover whether pharmacist-led delivery of oral anticoagulation therapy can lead to an increase in stroke risk reduction for patients with actionable atrial fibrillation.

Medication, Health Care Affordability Improved During COVID-19 Pandemic

Medication, Health Care Affordability Improved During COVID-19 Pandemic

Brian Nowosielski
July 15th 2024
Article

Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.

GLP-1s, SGLT2 Inhibitors Reduce Progression of CKD

GLP-1s, SGLT2 Inhibitors Reduce Progression of CKD

Brian Nowosielski
June 14th 2024
Article

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

Financial Incentives Show Significant Success for Weight Loss in Men

Financial Incentives Show Significant Success for Weight Loss in Men

Brian Nowosielski
May 22nd 2024
Article

Researchers analyzed groups of men given financial incentives to motivate weight-loss behaviors compared with a non-incentivized control group.

© 2025 MJH Life Sciences

All rights reserved.